高级检索
当前位置: 首页 > 详情页

A correlation study between cervical cancer and sex hormones

文献详情

资源类型:
Pubmed体系:
机构: [1]Health Management Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. [2]School of Public Health, Guizhou Medical University, Guiyang, Guizhou, China. [3]Institute of Environmental and School Hygiene and Disinfection, Sichuan Center For Disease Control and Prevention, Chengdu, China. [4]Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China.
出处:
ISSN:

关键词: cervical cancer follicle-stimulating hormone prolactin thin prep cytologic test sex hormones

摘要:
The aims of this study were to investigate the association between positive TCT and sex hormone levels and to evaluate the feasibility of change in sex hormone level as a potential predictor of cervical cancer.We recruited 910 female participants from the health examination center of a hospital in Guizhou between 2019 and 2023. All participants had undergone both hematologic examinations and cervical cancer screening.A total of 265 participants had positive TCT screening. Luteinizing hormone, estradiol, prolactin, and progesterone were negatively correlated with positive TCT screening. Age, systolic blood pressure, alanine aminotransferase, aspartate aminotransferase, urea, fasting blood glucose, low-density lipoprotein, total cholesterol, triglyceride, erythrocyte, follicle-stimulating hormone, and testosterone were positively correlated with positive TCT screening. Logistic regression analysis showed that prolactin, red blood cell count, and age were risk factors for cervical cancer, while FSH was a protective factor for cervical cancer. The AUC of FSH and age in the prediction model was 0.701 and 0.705, respectively.The incidence of cervical cancer increases with increased age and follicle poietin level. At the same time, the increase in FSH level has a certain predictive value for the incidence of cervical cancer.Copyright © 2024 Wu, You, Guan, Ban, Wang, Du, Wang, Wu, Wen, Ren, Wu, Zhang and Mo.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
第一作者:
第一作者机构: [1]Health Management Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53699 今日访问量:0 总访问量:4607 更新日期:2025-02-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号